Researchers identify low MCJ expression as marker of poor response to chemotherapy

[News]

Chemotherapy is a key part of the standard treatment regimen for triple-negative breast cancer patients whose cancer lacks expression of estrogen and progesterone receptors and the human epidermal growth factor receptor 2 (HER2).

More... (http://www.news-medical.net/news/20160520/Researchers-identify-low-MCJ-expression-as-marker-of-poor-response-to-chemotherapy.aspx)